Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 108,085 | 40,893 | 30,336 | 1,605 | 154 |
| Cost of Goods | 2,705 | 2,407 | N/A | N/A | N/A |
| Gross Profit | 105,380 | 38,486 | 30,336 | 1,605 | 154 |
| Operating Expenses | 277,935 | 228,168 | 210,219 | 132,143 | 110,886 |
| Operating Income | -171,850 | -189,275 | -179,883 | -130,538 | -110,732 |
| Interest Expense | 27,140 | 15,647 | 2,493 | 0 | 0 |
| Other Income | 3,026 | 5,372 | 3,995 | 1,617 | 1,294 |
| Pre-tax Income | -195,964 | -199,550 | -178,381 | -128,921 | -109,438 |
| Income Tax | 309 | 40 | 26 | 63 | 139 |
| Net Income Continuous | -196,273 | -199,590 | -178,407 | -128,984 | -109,577 |
| Net Income | $-196,273 | $-199,590 | $-178,407 | $-128,984 | $-109,577 |
| EPS Basic Total Ops | -40.78 | -48.28 | -47.08 | -42.13 | -43.78 |
| EPS Basic Continuous Ops | -40.84 | -48.30 | -47.11 | -42.13 | -43.78 |
| EPS Diluted Total Ops | -40.78 | -48.28 | -47.08 | -42.13 | -43.78 |
| EPS Diluted Continuous Ops | -40.84 | -48.30 | -47.11 | -42.13 | -43.78 |
| EPS Diluted Before Non-Recurring Items | -40.78 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-161,388 | $-182,490 | $-177,699 | $-128,638 | $-108,816 |